sulfisoxazole has been researched along with warfarin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Levy, G; Yacobi, A | 1 |
| Himberg, JJ; Julkunen, RJ | 1 |
| Warkany, J | 1 |
| Becker, MH; Finegold, M; Genieser, NB; Miranda, D; Spackman, T | 1 |
| Evans, W; Ferguson, T; Self, TH | 1 |
| Brater, DC; Kirchner, KA; Voelker, JR | 1 |
| Jatlow, P | 1 |
| Granatek, AP; Mihotic, MM; Prasad, VK | 1 |
| Pentel, PR; Sioris, LJ; Weibert, RT | 1 |
14 other study(ies) available for sulfisoxazole and warfarin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.
Topics: Adolescent; Adult; Animals; Blood Proteins; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Pharmaceutical Preparations; Phenytoin; Protein Binding; Rats; Salicylates; Serum Albumin; Sulfisoxazole; Time Factors; Transplantation, Homologous; Warfarin | 1977 |
Dry polyacrylamide batch method for studying drug protein binding.
Topics: Chromatography, Gel; Humans; Phenylbutazone; Protein Binding; Quinidine; Serum Albumin; Sulfadiazine; Sulfisoxazole; Warfarin | 1976 |
A warfarin embryopathy?
Topics: Abnormalities, Drug-Induced; Alcoholism; Chondrodysplasia Punctata; Diazepam; Digitalis Glycosides; Erythromycin; Female; Fetus; Heart Valve Prosthesis; Heparin; Humans; Infant, Newborn; Penicillin G Benzathine; Pregnancy; Pregnancy Complications; Sulfisoxazole; Syphilis; Thrombosis; Warfarin | 1975 |
Chondrodysplasis punctata: is maternal warfarin therapy a factor?
Topics: Abnormalities, Drug-Induced; Adult; Chondrodysplasia Punctata; Digitoxin; Digoxin; Female; Fetus; Heart Valve Prosthesis; Heparin; Humans; Infant, Newborn; Male; Placenta Diseases; Pregnancy; Pregnancy Complications; Radiography; Sulfisoxazole; Thrombosis; Warfarin | 1975 |
Letter: Interaction of sulfisoxazole and warfarin.
Topics: Aged; Drug Synergism; Heart Diseases; Humans; Male; Prothrombin Time; Pulmonary Embolism; Sulfisoxazole; Warfarin | 1975 |
Binding inhibitors restore furosemide potency in tubule fluid containing albumin.
Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Body Fluids; Dansyl Compounds; Drug Tolerance; Furosemide; Kidney Tubules, Distal; Male; Nephrotic Syndrome; Perfusion; Protein Binding; Rats; Rats, Inbred Strains; Sarcosine; Sulfisoxazole; Warfarin | 1991 |
Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences.
Topics: Acetaminophen; Barbiturates; Chlorothiazide; Chlorpropamide; Dicumarol; Humans; Methods; Nicotinic Acids; Oxyphenbutazone; Phenacetin; Phenindione; Phenobarbital; Phenylbutazone; Phenytoin; Salicylates; Spectrophotometry, Ultraviolet; Sulfamethoxazole; Sulfinpyrazone; Sulfisoxazole; Theobromine; Theophylline; Warfarin | 1973 |
Physical compatibility and chemical stability of cephapirin sodium in combination with non-antibiotic drugs in large-volume parenteral solutions. II.
Topics: Acetamides; Aminophylline; Ascorbic Acid; Barbiturates; Bicarbonates; Calcium Chloride; Cephalosporins; Chemical Phenomena; Chemistry; Diphenhydramine; Drug Combinations; Drug Incompatibility; Drug Stability; Epinephrine; Ergonovine; Heparin; Hydrocortisone; Hydrogen-Ion Concentration; Metaraminol; Nitrofurantoin; Norepinephrine; Phenytoin; Pyridines; Solutions; Succinylcholine; Sulfadiazine; Sulfides; Sulfisoxazole; Thiopental; Vitamins; Warfarin | 1974 |
Potentiation of warfarin anticoagulation by sulfisoxazole.
Topics: Aged; Blood Coagulation; Drug Synergism; Female; Humans; Pulmonary Embolism; Sulfisoxazole; Urinary Tract Infections; Warfarin | 1980 |